cancer-research

Documents about cancer-research

• Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup#677249HAL (France)
• Evaluation of a Mobile Digital Solution for Cancer Care and Research#834561ClinicalTrials.gov
• Taiwanese Anaplastic Thyroid Cancer Registry#832187ClinicalTrials.gov
• Mapping research trends in esophageal cancer immunotherapy: A decade of thematic evolution and emerging priorities#4617Europe PMC
• Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer#417601ClinicalTrials.gov
• Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer#6792OpenAlex
• First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer#825911ClinicalTrials.gov
• National Awareness and Early Diagnosis Initiative: Cancer Awareness Measure, 2008#207765UK Data Service OAI-PMH Repository (Production)
• National Awareness And Early Diagnosis Initiative: Cancer Awareness Measure, Anglia Cancer Network, 2009-2010#164241DataCite
• Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)#238101ClinicalTrials.gov
• SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer#824936ClinicalTrials.gov
• Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer#829953ClinicalTrials.gov
• Preoperative Imaging in Retroperitoneal Sarcoma#812784ClinicalTrials.gov
• Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC#184838ClinicalTrials.gov
• DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer#268093ClinicalTrials.gov
• PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations#803346ClinicalTrials.gov
• Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer#836762ClinicalTrials.gov
• Cancer Alley: Ruthless Murder for Financial Gain#675198DigitalCommons@CalPoly
• Cancer Research UK COVID Cancer Awareness Measures: Wave 1 and Wave 2, 2020-2021: Special Licence Access#470067UK Data Service OAI-PMH Repository (Production)
• ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer#832616ClinicalTrials.gov
• National Awareness and Early Diagnosis Initiative: Cancer Awareness Measure, Mount Vernon Cancer Network, 2010#164233DataCite
• National Awareness and Early Diagnosis Initiative: Cancer Awareness Measure, North London Cancer Network, 2010#164244DataCite
• Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer#398316ClinicalTrials.gov
• Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer#424231ClinicalTrials.gov
• HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy#459968ClinicalTrials.gov
• Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, Effectiveness#837823ClinicalTrials.gov
• VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy#217043ClinicalTrials.gov
• Combination Study of Antibiotics With Enzalutamide (PROMIZE)#363628ClinicalTrials.gov
• Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention#834039ClinicalTrials.gov
• Research on Laparoscopic Fertility-Sparing Surgery in Early-Stage Cervical Cancer#837543ClinicalTrials.gov
• Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer#804184ClinicalTrials.gov
• Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer#253066ClinicalTrials.gov
• A Clinical Research of CAR T Cells Targeting CEA Positive Colorectal Cancer (CRC)#801249ClinicalTrials.gov
• Efficacy of Tobacco Quitline for Cancer Survivors#832458ClinicalTrials.gov
• Research on tissue-resident macrophages in the field of cancer research: a bibliometric analysis from 2004 to 2025#4677Europe PMC
• Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer#804892ClinicalTrials.gov
• EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer#800200ClinicalTrials.gov
• ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort#801877ClinicalTrials.gov
• Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers#805709ClinicalTrials.gov
• Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients#805631ClinicalTrials.gov
• Prognostic biomarkers in ovarian cancer#129210PMC Full-Text (OAI)
• Preneoplasia of lung cancer#153464PMC Full-Text (OAI)
• Clinical code list - Breast Cancer#206179LSHTM Data Compass
• Evidence amalgamation, plausibility, and cancer research#700718PhilArchive
• Perceived colorectal cancer candidacy and the role of candidacy in colorectal cancer screening#684844Enlighten Publications
• INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer#811567ClinicalTrials.gov
• Investigating the Needs of Childhood Cancer Survivors: The Unreported Experience#824784ClinicalTrials.gov
• Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer#838105ClinicalTrials.gov
• Community perspectives and insights into cancer surveillance, prevention, and research: an engaged participatory approach to cancer epidemiology research in remote areas of Northeastern Uganda.#265502NCBI PubMed Central
• Identifying Research Practices Toward Achieving Health Equity Principles Within the Cancer Prevention and Control Research Network#228601Scholar Commons